Seòmar agus comataidhean

The Chief Pharmaceutical Officer is putting together a workforce forum to look at the workforce challenges and bringing together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

The Scottish Government will also continue to work with our key partners to ensure that the balance is maintained across the whole pharmacy workforce in the hospital, community, and GP practice sectors.

The Scottish Government workforce integrated plans commits to increasing the pharmacy pre-registration training places by 120 over the next 4 years and we are currently increasing training places available for pharmacy technician training, which will bring more staff in to the profession.

All patient conveying vehicles including paramedic response units carry defibrillators and staff are trained to use them. Community First responder vehicles also carry defibrillators, and the Scottish Ambulance Service has access to a system which is used to direct members of public to the closest registered defibrillator.

The refreshed Out of Hospital Cardiac Arrest (OHCA) Strategy 2021 to 2026, published in March recognises the importance of defibrillation registration. We are key partners within the Save a Life for Scotland Partnership (SALFS).

We would urge all defibrillator guardians to register their defibrillator so that the Scottish Ambulance Service call handlers can direct people to them in incidents of cardiac arrest. Registration of defibrillators in Scotland will build the evidence to support people and organisations in making informed decisions about where to place their life saving device.

Data on nationality is not collected as part of the COVID vaccination programme.

We commenced the collection of ethnicity data as part of the vaccination programme in November 2021. This is to help tackle racialised health inequalities. Once this data becomes available it will help us to better design and tailor services to improve people’s health outcomes. This data is collected following a recommendation from the Expert Reference Group on COVID and Ethnicity (ERG).

The ethnicity question is a mandatory field, and so everyone should complete this field, though there is an option for people to select the option ‘prefer not to say/don’t know’. The ethnicity question used is taken from Census 2022 Question 23.

Full information on what personal information we process , including ethnicity, and how we use your data as part of the COVID-19 vaccination programme can be found on NHS Inform under Data, Privacy and Ethics.

Public Health Scotland already publishes information about equality of vaccination uptake. The most recent data can be found at COVID-19 Statistical Report - 1 December 2021 - COVID-19 statistical report - Publications - Public Health Scotland . The report contains information about the data sources used.

The Scottish Government’s commitment to the early diagnosis of cancer is reflected in our £44m Detect Cancer Early (DCE) Programme, which adopts a whole-systems approach to diagnosing and treating cancer as early as possible – ranging from screening and public awareness campaigns to diagnostics and data. The NHS Recovery Plan, published August 2021, commits an additional £20m for the Programme.

In terms of data, Scotland already publishes a range of quality data-sets which include blood cancers. Some examples of these are our quarterly published Cancer Waiting Times data which includes lymphomas, our annually published Cancer Mortality data which has blood and lymphatic cancers included, and our annually published Cancer Survival stats which includes blood cancers.

In addition to this, the National Cancer Data Group is an established advisory group containing relevant clinicians and stakeholders, and meets regularly in order to seek improvements in data collection to, in turn, improve cancer outcomes in Scotland.

Our officials are currently in discussion with the Blood Cancer Alliance to arrange a meeting early this year, to explore how further improved outcomes for patients diagnosed with blood cancers can be achieved.

Marine Scotland – Licensing Operations Team (“MS-LOT”) intends to publish the written report by Seagreen Wind Energy Limited in respect of unexploded ordnance clearance activities on its website (marine.gov.scot) once the internal review of the report is complete.

The focus of Scottish Government remains on pandemic response and supporting the NHS and its entire workforce through this challenging winter and beyond. The wellbeing of the entire workforce of the NHS is a key priority which is why, in the current financial year, the Scottish Government has made over £12 million available to support the wellbeing of the workforce.

The Cabinet Secretary for Health and Social Care meets regularly with representatives from BMA Scotland, and other trade unions, to discuss and agree actions to support the entire NHS workforce. The next meeting between the Cabinet Secretary and the BMA will take place on 10th January. In addition there is a regular tripartite forum with Scottish Government, BMA and NHS employers which has a focus on all aspects of junior doctors working lives, and agrees and implements actions to improve these.

Through this group several important actions have been implemented including abolishing junior doctors working more than seven days in a row, and ensuring no junior doctors works for seven night shifts in a row.

We have agreed with BMA Scotland that we will work through this group to explore how we can implement the recommendations contained within the Junior Doctors - 48-hour Maximum Working Week (Without Averaging): Expert Working Group Report. This group will also consider the recommendations in the BMA report Supporting Junior Doctor Wellbeing – Now and for the Future .

The Scottish Government notes the updated National Institute for Health and Care Excellence (NICE) guidance on sapropterin published September 2021 following a resubmission by its manufacturer Biomarin. The Scottish Medicines Consortium (SMC) previously considered sapropterin (Kuvan) in August 2018 and the medicine was not recommended for use in NHSScotland because the submitting company’s justification of the treatment’s cost in relation to its health benefits was not sufficient and in addition the company did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC. The submitting company (BioMarin) has not been in contact with SMC regarding a resubmission for this medicine.

The first generic version of sapropterin has received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). To support ensuring best value for NHSScotland, NSS National Procurement will shortly be tendering for the future supply of sapropterin to NHS Scotland.

Given the launch of the first generic, we are currently considering how best to provide advice to Health Boards on whether sapropterin should be made available for routine use in NHSScotland, based on the latest available evidence.

The Scottish Government would expect all employers to ensure that all staff have the necessary rest breaks and support; and this was re-emphasised by the Chief Pharmaceutical Officer in her joint letter with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society, to the service on 8 December outlining the importance of wellbeing to all pharmacy staff and detailing support available.

The COVID-19 pandemic has shown to us all the value which the pharmacy profession bring to the NHS in Scotland be that hospital, community pharmacy or general practice settings. In particular the pharmacy network has been pivotal in the NHS response to the current pandemic in ensuring people across the country have continued access to their medicines and professional healthcare advice. We take the wellbeing of pharmacy teams very seriously and that is why we have made £12m available to support the wellbeing of the pharmacist workforce. That includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

Wider workforce issues and challenges will be discussed at the Chief Pharmaceutical Officer’s Workforce Forum, which will bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

I refer to member to the answer to question S6W-05124 on 10 January 2022. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.